CeriBell IPO: Stock price soars as AI brain-monitoring headband maker debuts on Nasdaq

The medtech startup, which operates an EEG platform that can detect seizures, had already priced shares above their expected range before they began trading.

CeriBell, a neurodiagnostic startup known for its brain-monitoring headband that can detect seizure activity, made its market debut on Friday in an IPO that is expected to generate $180.3 million in proceeds. Here’s what to know about the medtech company and its initial public offering: